Eric Hoffmann

Title: Eric Hoffmann: Innovator in Pharmaceutical Formulations

Introduction

Eric Hoffmann is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. His work focuses on enhancing the efficacy and stability of pharmaceutical products.

Latest Patents

Eric Hoffmann holds a patent for "Liquid pharmaceutical formulations of PTH conjugates." This patent describes a liquid pharmaceutical formulation that includes a PTH conjugate, a buffering agent, an isotonicity agent, a preservative, and optionally an antioxidant. The PTH conjugate consists of a PTH moiety that is covalently and reversibly conjugated to a water-soluble carrier moiety. This formulation aims to improve the delivery and effectiveness of therapeutic agents.

Career Highlights

Eric Hoffmann is currently employed at Ascendis Pharma Bone Diseases A/S, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in liquid formulations has positioned him as a key player in the development of new treatments for bone diseases.

Collaborations

Throughout his career, Eric has collaborated with talented professionals, including Anja R H Skands and Felix Cleemann. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Eric Hoffmann's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the healthcare sector. His work not only enhances the effectiveness of treatments but also showcases the importance of collaboration in scientific advancements.